SCHEMBL10187737

SCHEMBL10187737

CC(C)(C)[Si](O[C@@H]1CCN(C(=O)OCc2ccccc2)C1)(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
CYP2C19 P33261 1/20 0.50
HTT P42858 1/20 0.48
PDE4B Q07343 1/20 0.46
GRIN2B Q13224 9/20 0.46
CYP2D6 P10635 4/20 0.45
CYP2C9 P11712 4/20 0.45
PIK3CD O00329 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
USP30 Q70CQ3 1/20 0.43
CYP3A4 P08684 3/20 0.43
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
FAAH O00519 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1441247 1.00 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL5723900 0.91 SMN1; SMN2 (0.47) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL29869695 0.88 SMN1; SMN2 (0.42) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL28404252 0.87 TMEM97 (0.44) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL23275507 0.85 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL23275506 0.85 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL23275505 0.85 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL31460300 0.84 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL30065370 0.84 MEN1 (0.38) MEN1KMT2AUSP30
SCHEMBL30706703 0.82 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9ACYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2473505-A1 PYRAZINYLPYRIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES Novartis AG (CH) 2012-07-11 EP disclosed